Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial Agents and Chemotherapy 1999-12, Vol.43 (12), p.2831-2840
Hauptverfasser: LOUIE, A, WEIGUO LIU, MILLER, D. A, SUCKE, A. C, LIU, Q.-F, DRUSANO, G. L, MAYERS, M, MILLER, M. H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2840
container_issue 12
container_start_page 2831
container_title Antimicrobial Agents and Chemotherapy
container_volume 43
creator LOUIE, A
WEIGUO LIU
MILLER, D. A
SUCKE, A. C
LIU, Q.-F
DRUSANO, G. L
MAYERS, M
MILLER, M. H
description Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
doi_str_mv 10.1128/aac.43.12.2831
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17443128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17443128</sourcerecordid><originalsourceid>FETCH-LOGICAL-a507t-b628411a6ad4904851cb149344952963af4b82cb4ea089cefb87d6b01f807ef23</originalsourceid><addsrcrecordid>eNp9kkFv1DAQhQMC0aVwhCOyEOJCs9iOk3UkLst2S5GK4FDO1sRxGleOHeyksPx6nGYFiyo4WTP-3huP9ZLkOcFLQih_CyCXLFsSuqQ8I_eTBcElT4u8LB4kC4yLImUcs6PkcQjXONZ5iR8lRwTnnPKCL-492zaNliC1Csg16FxftempCwqdmVE6Cz-dUag3Y0Drrm_doLyW2qL3CGz9PzpPY8t5J3eDC9oqdKN8uONycig8ufW8I_zkrBta5aGf3hhVl17B0Ck7TA_e_uij2VSBQVtbOwm-1oMOJ7dV3w4tmG5uTPZfdso4q_rWTz10Oio0OLSJV7oGBKaKn2HDk-RhAyaop_vzOPl6tr3cnKcXnz983KwvUsjxakirgnJGCBRQsxIznhNZEVZmjJU5LYsMGlZxKiumAPNSqqbiq7qoMGk4XqmGZsfJu9m3H6tO1TKu4cGIPm4EficcaPH3jdWtuHI3gpf5Kovy13u5d99GFQbR6SCVMWCVG4MgK8aymJIILmdQeheCV83vEQSLKUdivd4IlglCxZSjKHgzCyB0VFy70dv4D_-mXxyucWA-xywCr_YABAmm8WClDn84SgtMWcRezlgbg_VdeyXieBEjfjjsF0hS8AU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17443128</pqid></control><display><type>article</type><title>Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>LOUIE, A ; WEIGUO LIU ; MILLER, D. A ; SUCKE, A. C ; LIU, Q.-F ; DRUSANO, G. L ; MAYERS, M ; MILLER, M. H</creator><creatorcontrib>LOUIE, A ; WEIGUO LIU ; MILLER, D. A ; SUCKE, A. C ; LIU, Q.-F ; DRUSANO, G. L ; MAYERS, M ; MILLER, M. H</creatorcontrib><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><identifier>ISSN: 0066-4804</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/aac.43.12.2831</identifier><identifier>PMID: 10582868</identifier><identifier>CODEN: AACHAX</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Amphotericin B ; Amphotericin B - pharmacokinetics ; Amphotericin B - therapeutic use ; Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antifungal Agents ; Antifungal Agents - pharmacokinetics ; Antifungal Agents - therapeutic use ; Biological and medical sciences ; Candida albicans ; Candida albicans - drug effects ; Candidiasis ; Candidiasis - drug therapy ; Candidiasis - metabolism ; Candidiasis - microbiology ; Creatinine - blood ; Endocarditis ; Endocarditis - drug therapy ; Endocarditis - metabolism ; Endocarditis - microbiology ; Endophthalmitis ; Endophthalmitis - drug therapy ; Endophthalmitis - metabolism ; Endophthalmitis - microbiology ; Experimental Therapeutics ; Fluconazole ; Fluconazole - pharmacokinetics ; Fluconazole - therapeutic use ; Flucytosine ; Flucytosine - pharmacokinetics ; Flucytosine - therapeutic use ; Kidney - metabolism ; Male ; Medical sciences ; Microbial Sensitivity Tests ; Myocardium - metabolism ; Pharmacology. Drug treatments ; Pyelonephritis ; Pyelonephritis - drug therapy ; Pyelonephritis - metabolism ; Pyelonephritis - microbiology ; Rabbits ; Survival Analysis ; Time Factors ; Vitreous Body - metabolism</subject><ispartof>Antimicrobial Agents and Chemotherapy, 1999-12, Vol.43 (12), p.2831-2840</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright © 1999 American Society for Microbiology</rights><rights>Copyright © 1999, American Society for Microbiology 1999</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a507t-b628411a6ad4904851cb149344952963af4b82cb4ea089cefb87d6b01f807ef23</citedby><cites>FETCH-LOGICAL-a507t-b628411a6ad4904851cb149344952963af4b82cb4ea089cefb87d6b01f807ef23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC89573/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC89573/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1226024$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10582868$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LOUIE, A</creatorcontrib><creatorcontrib>WEIGUO LIU</creatorcontrib><creatorcontrib>MILLER, D. A</creatorcontrib><creatorcontrib>SUCKE, A. C</creatorcontrib><creatorcontrib>LIU, Q.-F</creatorcontrib><creatorcontrib>DRUSANO, G. L</creatorcontrib><creatorcontrib>MAYERS, M</creatorcontrib><creatorcontrib>MILLER, M. H</creatorcontrib><title>Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans</title><title>Antimicrobial Agents and Chemotherapy</title><addtitle>Antimicrob. Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </description><subject>Amphotericin B</subject><subject>Amphotericin B - pharmacokinetics</subject><subject>Amphotericin B - therapeutic use</subject><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antifungal Agents</subject><subject>Antifungal Agents - pharmacokinetics</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Candida albicans</subject><subject>Candida albicans - drug effects</subject><subject>Candidiasis</subject><subject>Candidiasis - drug therapy</subject><subject>Candidiasis - metabolism</subject><subject>Candidiasis - microbiology</subject><subject>Creatinine - blood</subject><subject>Endocarditis</subject><subject>Endocarditis - drug therapy</subject><subject>Endocarditis - metabolism</subject><subject>Endocarditis - microbiology</subject><subject>Endophthalmitis</subject><subject>Endophthalmitis - drug therapy</subject><subject>Endophthalmitis - metabolism</subject><subject>Endophthalmitis - microbiology</subject><subject>Experimental Therapeutics</subject><subject>Fluconazole</subject><subject>Fluconazole - pharmacokinetics</subject><subject>Fluconazole - therapeutic use</subject><subject>Flucytosine</subject><subject>Flucytosine - pharmacokinetics</subject><subject>Flucytosine - therapeutic use</subject><subject>Kidney - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Myocardium - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Pyelonephritis</subject><subject>Pyelonephritis - drug therapy</subject><subject>Pyelonephritis - metabolism</subject><subject>Pyelonephritis - microbiology</subject><subject>Rabbits</subject><subject>Survival Analysis</subject><subject>Time Factors</subject><subject>Vitreous Body - metabolism</subject><issn>0066-4804</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kkFv1DAQhQMC0aVwhCOyEOJCs9iOk3UkLst2S5GK4FDO1sRxGleOHeyksPx6nGYFiyo4WTP-3huP9ZLkOcFLQih_CyCXLFsSuqQ8I_eTBcElT4u8LB4kC4yLImUcs6PkcQjXONZ5iR8lRwTnnPKCL-492zaNliC1Csg16FxftempCwqdmVE6Cz-dUag3Y0Drrm_doLyW2qL3CGz9PzpPY8t5J3eDC9oqdKN8uONycig8ufW8I_zkrBta5aGf3hhVl17B0Ck7TA_e_uij2VSBQVtbOwm-1oMOJ7dV3w4tmG5uTPZfdso4q_rWTz10Oio0OLSJV7oGBKaKn2HDk-RhAyaop_vzOPl6tr3cnKcXnz983KwvUsjxakirgnJGCBRQsxIznhNZEVZmjJU5LYsMGlZxKiumAPNSqqbiq7qoMGk4XqmGZsfJu9m3H6tO1TKu4cGIPm4EficcaPH3jdWtuHI3gpf5Kovy13u5d99GFQbR6SCVMWCVG4MgK8aymJIILmdQeheCV83vEQSLKUdivd4IlglCxZSjKHgzCyB0VFy70dv4D_-mXxyucWA-xywCr_YABAmm8WClDn84SgtMWcRezlgbg_VdeyXieBEjfjjsF0hS8AU</recordid><startdate>19991201</startdate><enddate>19991201</enddate><creator>LOUIE, A</creator><creator>WEIGUO LIU</creator><creator>MILLER, D. A</creator><creator>SUCKE, A. C</creator><creator>LIU, Q.-F</creator><creator>DRUSANO, G. L</creator><creator>MAYERS, M</creator><creator>MILLER, M. H</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><scope>5PM</scope></search><sort><creationdate>19991201</creationdate><title>Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans</title><author>LOUIE, A ; WEIGUO LIU ; MILLER, D. A ; SUCKE, A. C ; LIU, Q.-F ; DRUSANO, G. L ; MAYERS, M ; MILLER, M. H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a507t-b628411a6ad4904851cb149344952963af4b82cb4ea089cefb87d6b01f807ef23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Amphotericin B</topic><topic>Amphotericin B - pharmacokinetics</topic><topic>Amphotericin B - therapeutic use</topic><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antifungal Agents</topic><topic>Antifungal Agents - pharmacokinetics</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Candida albicans</topic><topic>Candida albicans - drug effects</topic><topic>Candidiasis</topic><topic>Candidiasis - drug therapy</topic><topic>Candidiasis - metabolism</topic><topic>Candidiasis - microbiology</topic><topic>Creatinine - blood</topic><topic>Endocarditis</topic><topic>Endocarditis - drug therapy</topic><topic>Endocarditis - metabolism</topic><topic>Endocarditis - microbiology</topic><topic>Endophthalmitis</topic><topic>Endophthalmitis - drug therapy</topic><topic>Endophthalmitis - metabolism</topic><topic>Endophthalmitis - microbiology</topic><topic>Experimental Therapeutics</topic><topic>Fluconazole</topic><topic>Fluconazole - pharmacokinetics</topic><topic>Fluconazole - therapeutic use</topic><topic>Flucytosine</topic><topic>Flucytosine - pharmacokinetics</topic><topic>Flucytosine - therapeutic use</topic><topic>Kidney - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Myocardium - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Pyelonephritis</topic><topic>Pyelonephritis - drug therapy</topic><topic>Pyelonephritis - metabolism</topic><topic>Pyelonephritis - microbiology</topic><topic>Rabbits</topic><topic>Survival Analysis</topic><topic>Time Factors</topic><topic>Vitreous Body - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LOUIE, A</creatorcontrib><creatorcontrib>WEIGUO LIU</creatorcontrib><creatorcontrib>MILLER, D. A</creatorcontrib><creatorcontrib>SUCKE, A. C</creatorcontrib><creatorcontrib>LIU, Q.-F</creatorcontrib><creatorcontrib>DRUSANO, G. L</creatorcontrib><creatorcontrib>MAYERS, M</creatorcontrib><creatorcontrib>MILLER, M. H</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial Agents and Chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LOUIE, A</au><au>WEIGUO LIU</au><au>MILLER, D. A</au><au>SUCKE, A. C</au><au>LIU, Q.-F</au><au>DRUSANO, G. L</au><au>MAYERS, M</au><au>MILLER, M. H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans</atitle><jtitle>Antimicrobial Agents and Chemotherapy</jtitle><stitle>Antimicrob. Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>1999-12-01</date><risdate>1999</risdate><volume>43</volume><issue>12</issue><spage>2831</spage><epage>2840</epage><pages>2831-2840</pages><issn>0066-4804</issn><eissn>1098-6596</eissn><coden>AACHAX</coden><abstract>Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>10582868</pmid><doi>10.1128/aac.43.12.2831</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial Agents and Chemotherapy, 1999-12, Vol.43 (12), p.2831-2840
issn 0066-4804
1098-6596
language eng
recordid cdi_proquest_miscellaneous_17443128
source MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Amphotericin B
Amphotericin B - pharmacokinetics
Amphotericin B - therapeutic use
Animals
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antifungal Agents
Antifungal Agents - pharmacokinetics
Antifungal Agents - therapeutic use
Biological and medical sciences
Candida albicans
Candida albicans - drug effects
Candidiasis
Candidiasis - drug therapy
Candidiasis - metabolism
Candidiasis - microbiology
Creatinine - blood
Endocarditis
Endocarditis - drug therapy
Endocarditis - metabolism
Endocarditis - microbiology
Endophthalmitis
Endophthalmitis - drug therapy
Endophthalmitis - metabolism
Endophthalmitis - microbiology
Experimental Therapeutics
Fluconazole
Fluconazole - pharmacokinetics
Fluconazole - therapeutic use
Flucytosine
Flucytosine - pharmacokinetics
Flucytosine - therapeutic use
Kidney - metabolism
Male
Medical sciences
Microbial Sensitivity Tests
Myocardium - metabolism
Pharmacology. Drug treatments
Pyelonephritis
Pyelonephritis - drug therapy
Pyelonephritis - metabolism
Pyelonephritis - microbiology
Rabbits
Survival Analysis
Time Factors
Vitreous Body - metabolism
title Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A53%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacies%20of%20High-Dose%20Fluconazole%20plus%20Amphotericin%20B%20and%20High-Dose%20Fluconazole%20plus%205-Fluorocytosine%20versus%20Amphotericin%20B,%20Fluconazole,%20and%205-Fluorocytosine%20Monotherapies%20in%20Treatment%20of%20Experimental%20Endocarditis,%20Endophthalmitis,%20and%20Pyelonephritis%20Due%20to%20Candida%20albicans&rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&rft.au=LOUIE,%20A&rft.date=1999-12-01&rft.volume=43&rft.issue=12&rft.spage=2831&rft.epage=2840&rft.pages=2831-2840&rft.issn=0066-4804&rft.eissn=1098-6596&rft.coden=AACHAX&rft_id=info:doi/10.1128/aac.43.12.2831&rft_dat=%3Cproquest_cross%3E17443128%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17443128&rft_id=info:pmid/10582868&rfr_iscdi=true